SHAC / SCP & CO Healthcare Acquisition Co - Class A - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

SHAC / SCP & CO Healthcare Acquisition Company Class A / CITADEL ADVISORS LLC - SC 13G/A Passive Investment

SC 13G/A 1 tm233066-25sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)* SCP & CO HEALTHCARE ACQUISITION COMPANY (Name of Issuer) Class A common stock, $0.0001 par value

SHAC / SCP & CO Healthcare Acquisition Company Class A / UBS OCONNOR LLC - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* SCP & CO Healthcare Acquisition Company (Name of Issuer) Shares of Class A common stock included as part of the units (Title of Class of Securities) 784065104 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Stateme

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

15-12G 1 ea170302-1512gscpandco.htm FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-39921 SCP & CO HEALTHCA

AMENDMENT TO INVESTMENT MANAGEMENT TRUST AGREEMENT

Exhibit 10.1 AMENDMENT TO INVESTMENT MANAGEMENT TRUST AGREEMENT THIS AMENDMENT TO INVESTMENT MANAGEMENT TRUST AGREEMENT (this “Amendment Agreement”), dated as of December 9, 2022, is made by and between SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the parties hereto

SCP & CO Healthcare Acquisition Company Amends Charter to Unwind Before Year-End and Announces December 9, 2022 as Amended Termination Date and Announces Key Dates in Connection with the Liquidation

Exhibit 99.1 SCP & CO Healthcare Acquisition Company Amends Charter to Unwind Before Year-End and Announces December 9, 2022 as Amended Termination Date and Announces Key Dates in Connection with the Liquidation Tampa, FL, Dec. 09, 2022 (GLOBE NEWSWIRE) - On December 8, 2022, the stockholders of SCP & CO Healthcare Acquisition Company (the ?Company?) approved an amendment to the Company?s amended

Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 8, 2022 SCP & CO HEALTHCARE ACQUISITION COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39921 85-4030703 (State or other jurisdiction of incorpora

CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SCP & CO HEALTHCARE ACQUISITION COMPANY

Exhibit 3.1 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SCP & CO HEALTHCARE ACQUISITION COMPANY SCP & CO HEALTHCARE ACQUISITION COMPANY, a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows: 1. The name of the Corporation is ?SCP & CO Healthcare Acquisition Company.? The original Certificate of Incorporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 2)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 2) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39921 SCP & CO Hea

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 21, 2022 SCP & CO Healthcare acquisition company (Exact name of registrant as specified in its charter) Delaware 001-39921 85-4030703 (State or other jurisdiction of incorpora

SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629

SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 VIA EDGAR October 3, 2022 U.S. Securities & Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, NE Washington, D.C. 20549 Attn: Howard Efron Re: SCP & CO Healthcare Acquisition Company Form 10-K for the Year Ended December 31, 2021 Filed March 28, 2022 File

SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629

CORRESP 1 filename1.htm SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 VIA EDGAR September 13, 2022 U.S. Securities & Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, NE Washington, D.C. 20549 Attn: Howard Efron Re: SCP & CO Healthcare Acquisition Company Form 10-K for the Year Ended December 31, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39921 SCP & CO He

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39921 SCP & CO Healthca

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39921 SCP & CO Healthc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39921 SCP & CO Healthca

Description of Registered Securities.*

Exhibit 4.2 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED As of December 31, 2020, SCP & CO Healthcare Acquisition Company (?we,? ?our,? ?us? or the ?Company?) had the following three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): (i) its uni

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39921 SCP & CO H

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 11, 2022 SCP & CO Healthcare acquisition company (Exact name of registrant as specified in its charter) Delaware 001-39921 85-4030703 (State or other jurisdiction of incorpor

SHAC / SCP & CO Healthcare Acquisition Company Class A / UBS OCONNOR LLC - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SCP & CO Healthcare Acquisition Company (Name of Issuer) Shares of Class A common stock included as part of the units (Title of Class of Securities) 784065104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check t

SHAC / SCP & CO Healthcare Acquisition Company Class A / BALYASNY ASSET MANAGEMENT LLC - SC 13G/A Passive Investment

SC 13G/A 1 d309838dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) SCP & CO Healthcare Acquisition Company (Name of Issuer) Common Stock (Title of Class of Securities) 784065104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d

SHAC / SCP & CO Healthcare Acquisition Company Class A / CITADEL ADVISORS LLC - SCP & CO HEALTHCARE ACQUISITION CO Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 (Amendment No. 1)* SCP & CO Healthcare Acquisition Company (Name of Issuer) Class A common stock, $0.0001 par value per share (the ?Shares?) (Title of Class o

SHAC / SCP & CO Healthcare Acquisition Company Class A / SCP & CO SPONSOR LLC - SC 13G Passive Investment

SC 13G 1 shacu-sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SCP & CO Healthcare Acquisition Company (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 784065 104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39921 SCP & CO Hea

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001-39921 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For P

NT 10-Q 1 d242123dnt10q.htm FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001-39921 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transitio

Indemnity Agreement, dated August 17, 2021, by and between the Company and Mohit Kaushal.

Exhibit 10.2 INDEMNITY AGREEMENT This INDEMNITY AGREEMENT (this ?Agreement?) is made as of August 17, 2021, by and between SCP & CO Healthcare Acquisition Company, a Delaware corporation (the ?Company?), and (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 17, 2021 SCP & CO Healthcare Acquisition Company (Exact name of registrant as specified in its charter) Delaware 001-39921 85-4030703 (State or other jurisdiction of incorporat

Letter Agreement, dated August 17, 2021, by and between the Company and Mohit Kaushal.

Exhibit 10.1 August 17, 2021 SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and among SCP & CO Healthcare Acquisition Company, a Delaware corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39921 SCP & CO Healthca

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ( Mark One ) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT

Table of Contents Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001-39921 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For P

NT 10-Q 1 d125846dnt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001-39921 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 SCP & CO Healthcare Acquisition Company (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) January 22, 2021 (Dat

SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 SCP & CO Healthcare Acquisition Company (Name of Issuer) Common Stock (Title of Class of Securities) 784065203 (CUSIP Number) January 22, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i

Description of Registered Securities.*

Exhibit 4.2 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED As of December 31, 2020, SCP & CO Healthcare Acquisition Company (?we,? ?our,? ?us? or the ?Company?) had the following three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): (i) its uni

Annual Report - FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39921

SCP & CO Healthcare Acquisition Company Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 15, 2021

Exhibit 99.1 SCP & CO Healthcare Acquisition Company Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 15, 2021 TAMPA, FL, March 11, 2021 ? SCP & CO Healthcare Acquisition Company (NASDAQ: SHACU) (the ?Company?) announced that, commencing March 15, 2021, holders of the units sold in the Company?s initial public offering may elect to separately trade shares o

Financial Statements and Exhibits, Other Events

8-K 1 d151243d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 11, 2021 SCP & CO Healthcare Acquisition Company (Exact name of registrant as specified in its charter) Delaware 001-39921 85-4030703 (State or oth

JOINT FILING AGREEMENT

EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the Class A common stock of SCP & CO Healthcare Acquisition Company, a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on

January 27, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G*/ (Rule 13d-102) SCP & CO Healthcare Acquisition Company (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 784065112** (CUSIP Number) January 27, 2021 Date of Event Which Requires Filing of the Statement Check the appropriate box to designate the rule pursuant to whi

SCP & CO HEALTHCARE ACQUISITION COMPANY INDEX TO FINANCIAL STATEMENT Page Audited Financial Statement of SCP & CO Healthcare Acquisition Company: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of January 26, 2021 F-3 Not

EX-99.1 Exhibit 99.1 SCP & CO HEALTHCARE ACQUISITION COMPANY INDEX TO FINANCIAL STATEMENT Page Audited Financial Statement of SCP & CO Healthcare Acquisition Company: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of January 26, 2021 F-3 Notes to Financial Statement F-4 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and the Board of Direct

Financial Statements and Exhibits, Other Events

8-K 1 d111651d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 26, 2021 (February 1, 2021) SCP & CO Healthcare Acquisition Company (Exact name of registrant as specified in its charter) Delaware 001-39921 85-

Amended and Restated Certificate of Incorporation.(2)

EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SCP & CO HEALTHCARE ACQUISITION COMPANY January 21, 2021 SCP & CO Healthcare Acquisition Company, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “SCP & CO Healthcare Acquisition Company” The original certificate

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 21, 2021 SCP & CO Healthcare Acquisition Company (Exact name of registrant as specified in its charter) Delaware 001-39921 85-4030703 (State or other jurisdiction of

SCP & CO Healthcare Acquisition Company Announces Closing of Upsized $230,000,000 Initial Public Offering, Including Full Exercise of the Over-Allotment Option

EX-99.2 Exhibit 99.2 SCP & CO Healthcare Acquisition Company Announces Closing of Upsized $230,000,000 Initial Public Offering, Including Full Exercise of the Over-Allotment Option Tampa, FL. January 27, 2021. SCP & CO Healthcare Acquisition Company (the “Company”) (NASDAQ: SHACU), announced the closing of its upsized initial public offering of 23,000,000 units at $10.00 per unit, including 3,000,

SCP & CO Healthcare Acquisition Company, a SPAC focused on acquiring a digital health business, announces pricing of upsized $200 Million initial public offering

EX-99.1 Exhibit 99.1 SCP & CO Healthcare Acquisition Company, a SPAC focused on acquiring a digital health business, announces pricing of upsized $200 Million initial public offering Tampa, FL. January 21, 2021. SCP & CO Healthcare Acquisition Company (the “Company”), announced today the pricing of its upsized initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are

Investment Management Trust Agreement, dated January 21, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee. (2)

EX-10.2 Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of January 21, 2021 by and between SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statement on Form

Letter Agreement, dated January 21, 2021, by and among the Company, its officers, its directors and the Sponsor. (2)

EX-10.1 Exhibit 10.1 January 21, 2021 SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among SCP & CO Healthcare Acquisition Company, a Delaware co

Warrant Agreement dated January 21, 2021 between Continental Stock Transfer & Trust Company and the Company. (2)

EX-4.1 Exhibit 4.1 SCP & CO HEALTHCARE ACQUISITION COMPANY and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated January 21, 2021 THIS WARRANT AGREEMENT (this “Agreement”), dated January 21, 2021, is by and between SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacit

Private Placement Warrants Purchase Agreement, dated January 21, 2021, by and between the Company and the Sponsor. (2)

EX-10.5 Exhibit 10.5 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of January 21, 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and among SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), and SCP & CO Sponsor, LLC, a Delaware

Administrative Support Agreement, dated January 21, 2021, by and between the Company and the Sponsor (2)

EX-10.4 Exhibit 10.4 SCP & CO HEALTHCARE ACQUISITION COMPANY 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 January 21, 2021 SCP & CO Sponsor, LLC 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement (this “Agreement”) by and among SCP & CO Healthcare Acquisition Company (the “Company”) and SCP & CO Sponsor, LLC (t

Registration Rights Agreement, dated January 21, 2021, by and between the Company and the Sponsor (2)

EX-10.3 Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 21, 2021, is made and entered into by and among SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), SCP & CO Sponsor, LLC, a Delaware limited liability company (the “Sponsor”) and the undersigned parties listed on the signature page hereto under

Underwriting Agreement, dated January 21, 2021, by and among the Company, Barclays Capital Inc. and Piper Sandler & Co., the several underwriters. (2)

EX-1.1 Exhibit 1.1 Execution Version 20,000,000 Units SCP & CO HEALTHCARE ACQUISITION COMPANY ($10.00 per Unit) UNDERWRITING AGREEMENT January 21, 2021 BARCLAYS CAPITAL INC. PIPER SANDLER & CO. As Representatives of the several Underwriters named in Schedule I attached hereto, c/o Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 c/o Piper Sandler & Co. 800 Nicollet Mall Minneapoli

$200,000,000 SCP & CO Healthcare Acquisition Company 20,000,000 Units

Form 424(b)(4) Table of Contents Index to Financial Statements Filed Pursuant to Rule 424(b)(4) Registration Nos.

- FORM 8-A12B

Form 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 SCP & CO Healthcare Acquisition Company (Exact Name of Registrant as Specified in Its Charter) Delaware 85-2252723 (State of Incorporation or Organization) (I.R.S. Employer Identifica

- FORM S-1MEF

Form S-1MEF As filed on January 21, 2021 with the U.S. Securities and Exchange Commission. Registration No. 333-249137 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCP & CO Healthcare Acquisition Company (Exact name of registrant as specified in its charter) Delaware 6770 85-2252723 (State or other jurisdic

-

CORRESP 1 filename1.htm January 19, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Attention: Todd Schiffman Re: SCP & CO Healthcare Acquisition Company Registration Statement on Form S-1 Filed September 29, 2020, as amended File No. 333-249137 Dear Sir or Madam: Pursuant

-

SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 January 19, 2021 VIA EDGAR U.S. Securities & Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, NE Washington, D.C. 20549 Attention: Todd Schiffman Re: SCP & CO Healthcare Acquisition Company Registration Statement on Form S-1 Filed September 29, 2020, as a

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.**

EX-4.4 3 d18295dex44.htm EX-4.4 Exhibit 4.4 WARRANT AGREEMENT SCP & CO HEALTHCARE ACQUISITION COMPANY and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated [], 2021 THIS WARRANT AGREEMENT (this “Agreement”), dated [], 2021, is by and between SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as war

-

CORRESP 1 filename1.htm SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 VIA EDGAR January 15, 2021 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, NE Washington, D.C. 20549 Attn: Todd K. Schiffman, Esq., Staff Attorney Re: SCP & CO Healthcare Acquisition Company Registration Statem

- FORM S-1/A

Form S-1/A Table of Contents Index to Financial Statements As filed with the U.S. Securities and Exchange Commission on January 15, 2021. Registration No. 333-249137 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCP & CO Healthcare Acquisition Company (Exact name of registrant as specified

Amended and Restated Certificate of Incorporation.**

EX-3.2 Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SCP & CO HEALTHCARE ACQUISITION COMPANY , 2021 SCP & CO Healthcare Acquisition Company, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “SCP & CO Healthcare Acquisition Company” The original certificate of incorp

- FORM S-1/A

Form S-1/A As filed with the U.S. Securities and Exchange Commission on January 11, 2021. Registration No. 333-249137 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCP & CO Healthcare Acquisition Company (Exact name of registrant as specified in its charter) Delaware 6770 85-2252723 (State

Form of Subscription Agreement by and among SCP & CO Sponsor, LLC and the anchor investors.*

EX-10.9 Exhibit 10.9 SCP & CO SPONSOR, LLC January [], 2021 Dear SCP & Co Sponsor, LLC, This letter agreement sets forth the terms of the agreement between SCP & Co Sponsor, LLC, a Delaware limited liability company (the “Company”), and certain investment funds and managed accounts managed by or affiliated with the undersigned subscriber (“Subscriber”). The Company is the sponsor of SCP & CO Healt

Specimen Unit Certificate. (1)

EX-4.1 Exhibit 4.1 NUMBER UNITS U SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 784065 112 SCP & CO Healthcare Acquisition Company UNITS CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE-HALF OF ONE REDEEMABLE WARRANT, EACH WHOLE WARRANT ENTITLING THE HOLDER TO PURCHASE ONE SHARE OF CLASS A COMMON STOCK THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one share of Class

Amended and Restated Certificate of Incorporation. (2)

EX-3.2 Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SCP & CO HEALTHCARE ACQUISITION COMPANY , 2021 SCP & CO Healthcare Acquisition Company, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “SCP & CO Healthcare Acquisition Company” The original certificate of incorp

Form of Registration Rights Agreement among the Registrant, SCP & CO Sponsor, LLC and the Holders signatory thereto.*

EX-10.3 Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [ ], 2021, is made and entered into by and among SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), SCP & CO Sponsor, LLC, a Delaware limited liability company (the “Sponsor”) and the undersigned parties listed on the signature page hereto under “Holde

Form of Compensation Committee Charter.*

EX-99.2 Exhibit 99.2 SCP & CO HEALTHCARE ACQUISITION COMPANY COMPENSATION COMMITTEE CHARTER Effective , 2021 I. PURPOSES The Compensation Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of SCP & CO Healthcare Acquisition Company (the “Company”) to: (A) assist the Board in overseeing the Company’s employee compensation policies and practices, including (i) determini

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant.*

EX-10.2 Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of , 2021 by and between SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statement on Form S-1, File

Form of Audit Committee Charter.*

EX-99.1 Exhibit 99.1 SCP & CO HEALTHCARE ACQUISITION COMPANY AUDIT COMMITTEE CHARTER Effective , 2021 I. PURPOSES The Audit Committee (the “Committee”) is appointed by the Board of Directors (the “Board”“) of SCP & CO Healthcare Acquisition Company (the “Company”) to assist the Board in its oversight of the accounting and financial reporting processes of the Company and the Company’s compliance wi

Specimen Class A Common Stock Certificate. (1)

EX-4.2 Exhibit 4.2 SHARES NUMBER C- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 784065 112 SCP & CO Healthcare Acquisition Company CLASS A COMMON STOCK THIS CERTIFIES THAT is the owner of fully paid and non-assessable shares of Class A common stock, par value $0.0001 per share (the “Common Stock’ ), of SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), transferable on t

Form of Underwriting Agreement.*

EX-1.1 Exhibit 1.1 17,500,000 Units SCP & CO HEALTHCARE ACQUISITION COMPANY ($10.00 per Unit) UNDERWRITING AGREEMENT January [●], 2021 BARCLAYS CAPITAL INC. PIPER SANDLER & CO. As Representatives of the several Underwriters named in Schedule I attached hereto, c/o Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 c/o Piper Sandler & Co. 800 Nicollet Mall Minneapolis, Minnesota 5540

Form of Code of Business Conduct and Ethics.*

EX-14 Exhibit 14 SCP & CO HEALTHCARE ACQUISITION COMPANY CODE OF BUSINESS CONDUCT AND ETHICS Effective , 2021 I.

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.*

EX-4.4 Exhibit 4.4 WARRANT AGREEMENT SCP & CO HEALTHCARE ACQUISITION COMPANY and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated [], 2021 THIS WARRANT AGREEMENT (this “Agreement”), dated [], 2021, is by and between SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capac

Specimen Warrant Certificate. (1)

EX-4.3 Exhibit 4.3 Form of Warrant Certificate [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW SCP & CO Healthcare Acquisition Company Incorporated Under the Laws of the State of Delaware CUSIP 784065 112 Warrant Certificate This Warrant Certificate certifies that [ ], or registe

Form of Administrative Services Agreement between the Registrant and SCP & CO Sponsor, LLC.*

EX-10.8 Exhibit 10.8 SCP & CO HEALTHCARE ACQUISITION COMPANY 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 , 2021 SCP & CO Sponsor, LLC 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement (this “Agreement”) by and among SCP & CO Healthcare Acquisition Company (the “Company”) and SCP & CO Sponsor, LLC (the “Sponso

Form of Private Placement Warrants Purchase Agreement between the Registrant and SCP & CO Sponsor, LLC.*

EX-10.4 Exhibit 10.4 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of [ ], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and among SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), and SCP & CO Sponsor, LLC, a Delaware limite

Form of Letter Agreement among the Registrant, SCP & CO Sponsor, LLC and each of the executive officers and directors of the Registrant.*

EX-10.1 Exhibit 10.1 , 2021 SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd., Suite 300 Tampa, FL 33629 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among SCP & CO Healthcare Acquisition Company, a Delaware corporation

Form of Nominating & Corporate Governance Committee Charter.*

EX-99.3 Exhibit 99.3 SCP & CO HEALTHCARE ACQUISITION COMPANY NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER Effective , 2021 I. INTRODUCTION The Nominating and Corporate Governance Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of SCP & CO Healthcare Acquisition Company (the “Company”) to: (i) identify and screen individuals qualified to serve as directors

Form of Indemnification Agreement (1)

EX-10.5 Exhibit 10.5 INDEMNITY AGREEMENT This INDEMNITY AGREEMENT (this “Agreement”) is made as of , 2021, by and between SCP & CO Healthcare Acquisition Company, a Delaware corporation (the “Company”), and (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided

- FORM S-1/A

Form S-1/A Table of Contents Index to Financial Statements As filed with the U.S. Securities and Exchange Commission on January 6, 2021. Registration No. 333-249137 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCP & CO Healthcare Acquisition Company (Exact name of registrant as specified

Certificate of Incorporation (1)

EX-3.1 Exhibit 3.1 CERTIFICATE OF INCORPORATION OF SCP & CO HEALTHCARE ACQUISITION COMPANY July 29, 2020 The undersigned, for the purposes of forming a corporation under the laws of the State of Delaware, does make, file, and record this Certificate of Incorporation (the “Certificate”), and does hereby certify as follows: ARTICLE I NAME The name of the corporation is SCP & CO Healthcare Acquisitio

Consent of R. David Kretschmer.*

EX-99.4 Exhibit 99.4 Consent to be Named as a Director Nominee In connection with the filing by SCP & CO Healthcare Acquisition Company of its Registration Statement on Form S-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being na

Consent of Randy Parker.*

EX-99.7 10 d18295dex997.htm EX-99.7 Exhibit 99.7 Consent to be Named as a Director Nominee In connection with the filing by SCP & CO Healthcare Acquisition Company of its Registration Statement on Form S-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the

Registration Statement - FORM S-1

Form S-1 Table of Contents Index to Financial Statements As filed with the U.S. Securities and Exchange Commission on September 29, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCP & CO Healthcare Acquisition Company (Exact name of registrant as specified in its charter) Delaware

Consent of Alan Gold.*

EX-99.5 8 d18295dex995.htm EX-99.5 Exhibit 99.5 Consent to be Named as a Director Nominee In connection with the filing by SCP & CO Healthcare Acquisition Company of its Registration Statement on Form S-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the

Securities Subscription Agreement between the Registrant and SCP & CO Sponsor, LLC. (1)

EX-10.7 Exhibit 10.7 SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd. Suite 300 Tampa, FL 33629 SCP & CO Sponsor, LLC 2909 W Bay to Bay Blvd. Suite 300 Tampa, FL 33629 RE: Securities Subscription Agreement Ladies and Gentlemen: This agreement (the “Agreement”) is entered into on July 29, 2020 by and between SCP & CO Sponsor, LLC, a Delaware limited liability company (the “Subscriber

Bylaws. (1)

EX-3.3 Exhibit 3.3 BY LAWS OF SCP & CO HEALTHCARE ACQUISITION COMPANY (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation’s regi

Promissory Note issued to SCP & CO Sponsor, LLC.*

EX-10.6 Exhibit 10.6 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE

Consent of Tim Main.*

EX-99.6 Exhibit 99.6 Consent to be Named as a Director Nominee In connection with the filing by SCP & CO Healthcare Acquisition Company of its Registration Statement on Form S-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being na

-

Table of Contents Index to Financial Statements As confidentially submitted to the Securities and Exchange Commission on August 25, 2020.

CERTIFICATE OF INCORPORATION SCP & CO HEALTHCARE ACQUISITION COMPANY July 29, 2020

EX-3.1 2 filename2.htm Exhibit 3.1 CERTIFICATE OF INCORPORATION OF SCP & CO HEALTHCARE ACQUISITION COMPANY July 29, 2020 The undersigned, for the purposes of forming a corporation under the laws of the State of Delaware, does make, file, and record this Certificate of Incorporation (the “Certificate”), and does hereby certify as follows: ARTICLE I NAME The name of the corporation is SCP & CO Healt

PROMISSORY NOTE Principal Amount: Up to $300,000 Dated as of July 29, 2020

EX-10.6 Exhibit 10.6 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE

BY LAWS SCP & CO HEALTHCARE ACQUISITION COMPANY (THE “CORPORATION”) ARTICLE I

EX-3.3 3 filename3.htm Exhibit 3.3 BY LAWS OF SCP & CO HEALTHCARE ACQUISITION COMPANY (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Co

SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd. Suite 300 Tampa, FL 33629

EX-10.7 Exhibit 10.7 SCP & CO Healthcare Acquisition Company 2909 W Bay to Bay Blvd. Suite 300 Tampa, FL 33629 SCP & CO Sponsor, LLC 2909 W Bay to Bay Blvd. Suite 300 Tampa, FL 33629 RE: Securities Subscription Agreement Ladies and Gentlemen: This agreement (the “Agreement”) is entered into on July 29, 2020 by and between SCP & CO Sponsor, LLC, a Delaware limited liability company (the “Subscriber